flecainide has been researched along with Inadequate Sleep in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sauvet, F | 1 |
| Erblang, M | 1 |
| Gomez-Merino, D | 1 |
| Rabat, A | 1 |
| Guillard, M | 1 |
| Dubourdieu, D | 1 |
| Lefloch, H | 1 |
| Drogou, C | 1 |
| Van Beers, P | 1 |
| Bougard, C | 1 |
| Bourrrilhon, C | 1 |
| Arnal, P | 1 |
| Rein, W | 1 |
| Mouthon, F | 1 |
| Brunner-Ferber, F | 1 |
| Leger, D | 1 |
| Dauvilliers, Y | 1 |
| Chennaoui, M | 1 |
| Charvériat, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects[NCT03182413] | Phase 1 | 20 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for flecainide and Inadequate Sleep
| Article | Year |
|---|---|
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.
Topics: Adult; Arousal; Cognition; Connexins; Cross-Over Studies; Drug Combinations; Flecainide; Healthy Vol | 2019 |